9th Feb 2009 12:00
Full Year 2008 results date notification - 19 February 2008
February 9, 2008 - Shire plc , the global specialtybiopharmaceutical company, will announce full year 2008 earnings on Thursday 19February 2009.Results press release will be 12:00 GMT / 07:00 EST issued at:
Investor meeting and conference 14:00 GMT / 09:00 EST call time:
Investor & Analyst meeting and conference call:
Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Gr©goire, President, Human Genetic Therapies will host the investor and analyst meeting and conference call at 14:00 GMT/9:00 EST.
The meeting will take place at the offices of Deutsche Bank, Winchester House, 1 Great Winchester Street, London, EC2N 2DB.
Please email ssalah@shire.com to register to attend this meeting in London.
The details of the conference call are as follows:
UK and International 44 (0)20 7806 1957
dial in US dial in: 1 718 354 1388 Password/Conf ID: 9465839 Live Webcast: http://www.shire.com/shire/InvestorRelations/ quarterlyresults.jsp?tn=2&m1=48 Replay:
A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:
UK and International 44 (0)20 7806 1970
dial in US dial in 1 718 354 1112 Pin code 9465839# Webcast replay: http://www.shire.com/shire/InvestorRelations/ quarterlyresults.jsp?tn=2&m1=48
For further information please contact:
Investor Relations Souheil Salah +44 1256 894 160 Ricki Greenwood +1 (484) 595-8517 Notes to editorsSHIRE PLC
Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company's website: www.shire.com.
2Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PXPress Release
www.shire.com
vendorRelated Shares:
Shire